Nucleus Network

Running trials

• Recruiting

  A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants

  NCT07836452· Phase 1· Source

• Recruiting

  A Study of HL40626S Tablets in Healthy Adults

  NCT07736586· Phase 1· Source

• Recruiting

  A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

  NCT07628127· Phase 1· Source

• Recruiting

  SAD Study of CGB3002 in Healthy Participants

  NCT07660341· Phase 1· Source

• Recruiting

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

  NCT07577817· Early phase 1· Source

• Recruiting

  A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

  NCT07276958· Phase 1· Source

• Recruiting

  An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.

  NCT06891287· Phase 1· Source

• Recruiting

  Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers

  NCT07184502· Phase 1· Source

• Recruiting

  A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

  NCT06874010· Phase 1/2· Source

• Active, not recruiting

  A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

  NCT05345509· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Alzheimer disease1 recruiting
• Chronic kidney disease1 recruiting
• Friedreich ataxia1 recruiting
• Lupus (SLE)1 recruiting
• Psoriasis1 recruiting
• Rheumatoid arthritis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  A Phase 1 Study of Cizutamig in IgE Mediated Diseases

  NCT07408869· Phase 1· Source

• Recruiting

  A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

  NCT07641634· Phase 1/2· Source

• Recruiting

  Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

  NCT07207954· Phase 1· Source

• Completed

  Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.

  NCT07035990· Phase 1· Source

• Completed

  A Study of Atorvo+™ in Healthy Adult Participants

  NCT06615284· Phase 1· Source

• Completed

  A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease

  NCT06343636· Phase 1· Source

• Completed

  Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

  NCT04215978· Phase 1· Source